4//SEC Filing
Robinson Ryan F. 4
Accession 0001997834-25-000004
CIK 0001827506other
Filed
Oct 23, 8:00 PM ET
Accepted
Oct 24, 5:08 PM ET
Size
7.1 KB
Accession
0001997834-25-000004
Insider Transaction Report
Form 4
Robinson Ryan F.
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-10-22$13.92/sh+14,366$199,975→ 14,366 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-10-22−14,366→ 25,845 totalExercise: $13.92Exp: 2033-08-14→ Common Stock (14,366 underlying)
Footnotes (1)
- [F1]The shares subject to the option vested as to 25% of the shares on July 5, 2024 with the remainder vesting in the following 36 equal monthly installments, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Tourmaline Bio, Inc.
CIK 0001827506
Entity typeother
Related Parties
1- filerCIK 0001997834
Filing Metadata
- Form type
- 4
- Filed
- Oct 23, 8:00 PM ET
- Accepted
- Oct 24, 5:08 PM ET
- Size
- 7.1 KB